G. Michael Vincent
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
G. Michael Vincent has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Li Zhang
LDS Hospital and University of Utah School of Medicine
6 shared publicationsD. Woodrow Benson
2 shared publicationsIgor Splawski
LDS Hospital, Salt Lake City, Utah, USA
2 shared publicationsKatherine W. Timothy
LDS Hospital, Salt Lake City, Utah, USA
2 shared publicationsMark T. Keating
LDS Hospital, Salt Lake City, Utah, USA
2 shared publicationsAharon Medina
1 shared publication
Latest Publications
- 1 September 2005
- Published by Springer Nature in Molecular Diagnosis
- Vol. 9 (3) , 106-118
The Role of Genotyping in Diagnosing Cardiac Channelopathies
- 1 September 2005
- Published by Springer Nature in Molecular Diagnosis
- Vol. 9 (3) , 106-118
The Role of Genotyping in Diagnosing Cardiac Channelopathies
- 31 May 2005
- Published by Wolters Kluwer Health in Circulation
- Vol. 111 (21) , 2720-2726
Electrocardiographic Features in Andersen-Tawil Syndrome Patients With KCNJ2 Mutations
Background— The ECG features of Andersen-Tawil syndrome (ATS) patients with KCNJ2 mutations (ATS1) have not been systematically assessed. This study aimed to define ECG features of KCNJ2 mutation carriers, to determine whether characteristic T-U–wave patterns exist, and to establish whether T-U patterns predict the ATS1 genotype. Methods and Results— In phase I, evaluation of T-U morphology in ECGs of 39 KCNJ2 mutation carriers identified characteristic T-U patterns: prolonged terminal T downslope, wide T-U junction, and biphasic and enlarged U waves. In phase II, ATS1 genotype prediction by T-U pattern was evaluated in the next 147 ECGs (57 other KCNJ2 mutation carriers, 61 unaffected family members, and 29 ATS patients without KCNJ2 mutations), with a sensitivity of 84% and specificity of 97%. Characteristic T-U patterns were present in 91% (87/96), in whom an enlarged U wave was predominant (73%). In phase III, QTc, QUc, and T- and U-wave duration/amplitude were compared in the 96 ATS1, 29 non- KCNJ2 ATS, and 75 normal subjects. In ATS1 patients, QUc, U-wave duration and amplitude, and QTc were all increased ( P KCNJ2 patients. Conclusions— In ATS1 patients, gene-specific T-U–wave patterns resulting from decreased I K1 owing to KCNJ2 mutations can aid diagnosis and direct genotyping. The normal QTc, distinct ECG, and other clinical features distinguish ATS1 from long-QT syndrome, and it is best designated as ATS1 rather than LQT7.
- 31 May 2005
- Published by Wolters Kluwer Health in Circulation
- Vol. 111 (21) , 2720-2726
Electrocardiographic Features in Andersen-Tawil Syndrome Patients With KCNJ2 Mutations
Background— The ECG features of Andersen-Tawil syndrome (ATS) patients with KCNJ2 mutations (ATS1) have not been systematically assessed. This study aimed to define ECG features of KCNJ2 mutation carriers, to determine whether characteristic T-U–wave patterns exist, and to establish whether T-U patterns predict the ATS1 genotype. Methods and Results— In phase I, evaluation of T-U morphology in ECGs of 39 KCNJ2 mutation carriers identified characteristic T-U patterns: prolonged terminal T downslope, wide T-U junction, and biphasic and enlarged U waves. In phase II, ATS1 genotype prediction by T-U pattern was evaluated in the next 147 ECGs (57 other KCNJ2 mutation carriers, 61 unaffected family members, and 29 ATS patients without KCNJ2 mutations), with a sensitivity of 84% and specificity of 97%. Characteristic T-U patterns were present in 91% (87/96), in whom an enlarged U wave was predominant (73%). In phase III, QTc, QUc, and T- and U-wave duration/amplitude were compared in the 96 ATS1, 29 non- KCNJ2 ATS, and 75 normal subjects. In ATS1 patients, QUc, U-wave duration and amplitude, and QTc were all increased ( P KCNJ2 patients. Conclusions— In ATS1 patients, gene-specific T-U–wave patterns resulting from decreased I K1 owing to KCNJ2 mutations can aid diagnosis and direct genotyping. The normal QTc, distinct ECG, and other clinical features distinguish ATS1 from long-QT syndrome, and it is best designated as ATS1 rather than LQT7.
- 1 March 2005
- Published by Elsevier in Seminars in Pediatric Neurology
- Vol. 12 (1) , 15-24
The Long QT and Brugada Syndromes: Causes of Unexpected Syncope and Sudden Cardiac Death in Children and Young Adults
- 1 March 2005
- Published by Elsevier in Seminars in Pediatric Neurology
- Vol. 12 (1) , 15-24
The Long QT and Brugada Syndromes: Causes of Unexpected Syncope and Sudden Cardiac Death in Children and Young Adults
- 1 January 2005
- Published by Springer Nature in Molecular Diagnosis
- Vol. 9 (3) , 105-118
The Role of Genotyping in Diagnosing Cardiac Channelopathies
The role of genotyping for diagnosis of the cardiac ion channelopathies is a work in progress. No formal guidelines or other publications discussing current recommendations for genotyping exist, particularly for clinical/commercial genotyping. Further, the field is changing rapidly, opinions vary and, additionally, circumstances inside the US are different from outside. The following considerations are a current summary based on a review of the literature, discussions with experts in the field, and our own opinions and also include a brief discussion about genotyping for therapeutic decision making. Research-based genotyping is very important for continued understanding of the details of pathophysiology and the complex regulatory processes in these diseases. Clinical/commercial genotyping for diagnosis is important for identifying patients with reduced penetrance of the phenotype since effective therapies to prevent sudden death exist. Clinical genotyping for therapeutic advantage has limited application at present but will become much more important if and when genotype-/mutation-type specific therapies are shown to be effective. The recommendations will progressively change as new research findings and new genotyping technologies appear.
- 1 January 2005
- Published by Springer Nature in Molecular Diagnosis
- Vol. 9 (3) , 105-118
The Role of Genotyping in Diagnosing Cardiac Channelopathies
The role of genotyping for diagnosis of the cardiac ion channelopathies is a work in progress. No formal guidelines or other publications discussing current recommendations for genotyping exist, particularly for clinical/commercial genotyping. Further, the field is changing rapidly, opinions vary and, additionally, circumstances inside the US are different from outside. The following considerations are a current summary based on a review of the literature, discussions with experts in the field, and our own opinions and also include a brief discussion about genotyping for therapeutic decision making. Research-based genotyping is very important for continued understanding of the details of pathophysiology and the complex regulatory processes in these diseases. Clinical/commercial genotyping for diagnosis is important for identifying patients with reduced penetrance of the phenotype since effective therapies to prevent sudden death exist. Clinical genotyping for therapeutic advantage has limited application at present but will become much more important if and when genotype-/mutation-type specific therapies are shown to be effective. The recommendations will progressively change as new research findings and new genotyping technologies appear.
- 1 February 2002
- Published by Springer Nature in Cardiac Electrophysiology Review
- Vol. 6 (1-2) , 57-60
Congenital Long QT Syndrome
- 1 February 2002
- Published by Springer Nature in Cardiac Electrophysiology Review
- Vol. 6 (1-2) , 57-60
Congenital Long QT Syndrome
- 1 May 2001
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 12 (5) , 546-7
Prevention of drug-induced long QT syndrome: gender, chemistry, and education.
- 1 May 2001
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 12 (5) , 546-7
Prevention of drug-induced long QT syndrome: gender, chemistry, and education.
- 5 December 2000
- Published by Wolters Kluwer Health in Circulation
- Vol. 102 (23) , 2849-2855
Spectrum of ST-T–Wave Patterns and Repolarization Parameters in Congenital Long-QT Syndrome
Background —Congenital long-QT syndrome (LQTS) is caused by mutations of genes encoding the slow component of the delayed rectifier current (LQT1, LQT5), the rapid component of the delayed rectifier current (LQT2, LQT6), or the Na + current (LQT3), resulting in ST-T–wave abnormalities on the ECG. This study evaluated the spectrum of ST-T–wave patterns and repolarization parameters by genotype and determined whether genotype could be identified by ECG. Methods and Results —ECGs of 284 gene carriers were studied to determine ST-T–wave patterns, and repolarization parameters were quantified. Genotypes were identified by individual ECG versus family-grouped ECG analysis in separate studies using ECGs of 146 gene carriers from 29 families and 233 members of 127 families undergoing molecular genotyping, respectively. Ten typical ST-T patterns (4 LQT1, 4 LQT2, and 2 LQT3) were present in 88% of LQT1 and LQT2 carriers and in 65% of LQT3 carriers. Repolarization parameters also differed by genotype. A combination of quantified repolarization parameters identified genotype with sensitivity/specificity of 85%/70% for LQT1, 83%/94% for LQT2, and 47%/63% for LQT3. Typical patterns in family-grouped ECGs best identified the genotype, being correct in 56 of 56 (21 LQT1, 33 LQT2, and 2 LQT3) families with mutation results. Conclusions —Typical ST-T–wave patterns are present in the majority of genotyped LQTS patients and can be used to identify LQT1, LQT2, and possibly LQT3 genotypes. Family-grouped ECG analysis improves genotype identification accuracy. This approach can simplify genetic screening by targeting the gene for initial study. The multiple ST-T patterns in each genotype raise questions regarding the pathophysiology and regulation of repolarization in LQTS.
- 5 December 2000
- Published by Wolters Kluwer Health in Circulation
- Vol. 102 (23) , 2849-2855
Spectrum of ST-T–Wave Patterns and Repolarization Parameters in Congenital Long-QT Syndrome
Background —Congenital long-QT syndrome (LQTS) is caused by mutations of genes encoding the slow component of the delayed rectifier current (LQT1, LQT5), the rapid component of the delayed rectifier current (LQT2, LQT6), or the Na + current (LQT3), resulting in ST-T–wave abnormalities on the ECG. This study evaluated the spectrum of ST-T–wave patterns and repolarization parameters by genotype and determined whether genotype could be identified by ECG. Methods and Results —ECGs of 284 gene carriers were studied to determine ST-T–wave patterns, and repolarization parameters were quantified. Genotypes were identified by individual ECG versus family-grouped ECG analysis in separate studies using ECGs of 146 gene carriers from 29 families and 233 members of 127 families undergoing molecular genotyping, respectively. Ten typical ST-T patterns (4 LQT1, 4 LQT2, and 2 LQT3) were present in 88% of LQT1 and LQT2 carriers and in 65% of LQT3 carriers. Repolarization parameters also differed by genotype. A combination of quantified repolarization parameters identified genotype with sensitivity/specificity of 85%/70% for LQT1, 83%/94% for LQT2, and 47%/63% for LQT3. Typical patterns in family-grouped ECGs best identified the genotype, being correct in 56 of 56 (21 LQT1, 33 LQT2, and 2 LQT3) families with mutation results. Conclusions —Typical ST-T–wave patterns are present in the majority of genotyped LQTS patients and can be used to identify LQT1, LQT2, and possibly LQT3 genotypes. Family-grouped ECG analysis improves genotype identification accuracy. This approach can simplify genetic screening by targeting the gene for initial study. The multiple ST-T patterns in each genotype raise questions regarding the pathophysiology and regulation of repolarization in LQTS.
- 1 November 2000
- Published by Taylor & Francis in The Physician and Sportsmedicine
- Vol. 28 (11) , 31-39
Commotio Cordis
Commotio cordis is arrhythmia or sudden death from low-impact, blunt trauma to the chest without apparent heart injury. Ventricular fibrillation is the most common associated arrhythmia, and heart block, bundle branch block, and ST-segment elevation are also seen. Commotio cordis occurs most commonly in baseball but has also been reported in hockey, softball, and several other sports. Approximately two to four cases are reported each year, but the true incidence is uncertain. Survival is low, even when resuscitation is performed. Preventive measures include education of participants and coaches, chest protection, and softer baseballs. Other considerations include having external automatic defibrillators and trained personnel at youth sporting events.
- 1 November 2000
- Published by Taylor & Francis in The Physician and Sportsmedicine
- Vol. 28 (11) , 31-39
Commotio Cordis
Commotio cordis is arrhythmia or sudden death from low-impact, blunt trauma to the chest without apparent heart injury. Ventricular fibrillation is the most common associated arrhythmia, and heart block, bundle branch block, and ST-segment elevation are also seen. Commotio cordis occurs most commonly in baseball but has also been reported in hockey, softball, and several other sports. Approximately two to four cases are reported each year, but the true incidence is uncertain. Survival is low, even when resuscitation is performed. Preventive measures include education of participants and coaches, chest protection, and softer baseballs. Other considerations include having external automatic defibrillators and trained personnel at youth sporting events.